Gilead exercises option for Assembly Bio's herpes treatment programs Dec 22, 2025 08:02AM
Gilead Sciences Exercises Option to License Assembly Biosciences’ Helicase-Primase Inhibitor Programs for Recurrent Genital Herpes Dec 22, 2025 08:00AM
Gilead Sciences (GILD) and Assembly Biosciences (ASMB) Establish Partnership to Develop Next-Generation Therapeutics for Serious Viral Diseases Oct 17, 2023 07:00AM
Gilead and Assembly Biosciences Establish Partnership to Develop Next-Generation Therapeutics for Serious Viral Diseases Oct 17, 2023 07:00AM
Assembly Biosciences (ASMB) and BeiGene (BGNE) Announce License and Collaboration Agreement in China Jul 20, 2020 06:33AM


Jul 20, 2020 06:30AM Assembly Biosciences and BeiGene Announce License and Collaboration Agreement in China for Assembly’s Portfolio of Three Clinical-Stage Core Inhibitors for Chronic Hepatitis B Infection
Jul 20, 2020 06:30AM Assembly Biosciences and BeiGene Announce License and Collaboration Agreement in China for Assembly’s Portfolio of Three Clinical-Stage Core Inhibitors for Chronic Hepatitis B Infection